Olympus Corporation of the Americas

What they do

Olympus Corporation of the Americas is the US subsidiary of the century-old Japanese medical technology leader, Olympus Corporation. In 2021, the company launched Olympus Innovation Ventures (OIV) to generate a robust pipeline of M&A opportunities, partnerships, and market insights. OIV operates as a strategic CVC, partnering with outsourced venture management firm Cerity Partners Ventures to source and execute deals. The firm is highly regarded in the MedTech ecosystem for providing startups with unparalleled access to clinical expertise, regulatory guidance, and global distribution networks, particularly in endoscopy-related fields.

What they look for

OIV invests in passionate founders building customer-driven solutions in medical devices, diagnostics, and digital health that complement or extend Olympus' market-leading endoscopic solutions. They prioritize startups developing therapeutic and diagnostic solutions in targeted medical specialties-specifically Gastroenterology (GI), Urology, and Respiratory care. They look for "innovative partnerships" where Olympus can integrate portfolio solutions into its broader ecosystem to improve clinical outcomes, reduce healthcare costs, and enhance patient quality of life.

Stage

Seed, Series A, Series B+

Sectors

Healthcare, Deeptech, AI, SaaS

Based

Center Valley, US